Table 2.
Advantages | Limitations | |
---|---|---|
Sanger sequencing | • Time-efficient and cost-effective for low numbers of targets • Single base-pair resolution • 5% minor allele fractions can be detected • Contiguous sequences as long as 1000 bases can be analyzed • Useful in NGS confirmation |
• Not cost-effective for high target numbers • Low scalability due to increasing sample input requirements |
NGS | • Sequencing multiple genes/ targets simultaneously • High sample throughput • Single base-pair resolution • Higher probability to find novel variants • Increased sequencing depth resulting in higher sensitivity (down to 1%) |
• Less cost-effective and less time-efficient for sequencing low target numbers (up to 20) • Big data interpretation is needed |
Single nucleotide polymorphism genotyping | • Cost-effective for SNPs • Time-efficient results • Can be scaled up in multiplex SNP assays |
• Interrogating one SNP at a time • Investigates point mutations and not DNA aberrations |
Biochip array technology | • ICD certified (based on the British population) • The mutational status can be determined from a single test |
• Fixed number of investigated mutations/SNPs • Limited published data available |
Multiplex ligation-dependent probe amplification | • Golden standard technique for CNV (microdeletions, microduplications) identification • P-062 investigates 33 LDLR targets in one reaction • IVD certified • Multiplex, easy workflow, and low-cost technique |
• Investigates only the LDLR gene • Unable to detect anomalies at the single cell level • Cannot detect unknown point mutations • Sensitive to novel/undescribed benign polymorphisms at or near a probe ligation site |